Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer

Oncology (Switzerland)

Volumn 92, Issue 6, 2017, Pages 360-370

  Tsukamoto, Mitsuo ^a   Iinuma, Hisae ^a   Yagi, Takahiro ^a   Matsuda, Keiji ^a   Hashiguchi, Yojiro ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Biomarker; Colorectal cancer; Exosome; Liquid biopsy; MicroRNA 21

Indexed keywords

BIOLOGICAL MARKER; MICRORNA 21; MICRORNA; MIRN21 MICRORNA, HUMAN; TUMOR MARKER;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COLORECTAL CANCER; DISEASE FREE SURVIVAL; EXOSOME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; UPREGULATION; BLOOD; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; MORTALITY; PATHOLOGY; PROGNOSIS; SECONDARY; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR RECURRENCE; VALIDATION STUDY;

BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICROARRAY ANALYSIS; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 85017134879     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000463387     Document Type: Article

References (36)

1. Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Aggarwal S, Chu E: Current therapies for advanced colorectal cancer. Oncology 2005; 19: 589-595.
3. Chung KY, Kelsen D: Adjuvant therapy for stage II colorectal cancer; who and with what? Curr Treat Options Gastroenterol 2006; 9: 272-280.
4. Yang IP, Tsai HL, Miao ZF, Huang CW, Kuo CH, Wu JY, Wang WM, Juo SH, Wang JY: Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients. J Transl Med 2016; 14: 108.
5. Yi R, Li Y, Wang FL, Miao G, Qi RM, Zhao YY: MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer. World J Gastrointest Oncol 2016; 8: 330-340.
6. Deng D, Liu Z, Du Y: Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers. Adv Genet 2010; 71: 125-176.
7. Grady WM, Tewari M: The next thing in prognostic molecular markers: microRNA signatures of cancer. Gut 2010; 59: 706-708.
8. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
9. Du M, Liu S, Gu D, Wang Q, Zhu L, Kang M, Shi D, Chu H, Tong N, Chen J, Adams TS, Zhang Z, Wang M: Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Carcinogenesis 2014; 35: 2723-2730.
10. Hur K, Toiyama Y, Okugawa Y, Ide S, Imaoka H, Boland CR, Goel A: Circulating micro-RNA-203 predicts prognosis and metastasis in human colorectal cancer. Gut 2017; 66: 654-665.
11. Kowal J, Tkach M, Thery C: Biogenesis and secretion of exosomes. Curr Opin Cell Biol 2014; 29: 116-125.
12. Ge Q, Zhou Y, Lu J, Bai Y, Xie X, Lu Z: miRNA in plasma exosome is stable under different storage conditions. Molecules 2014; 19: 1568-1575.
13. Palma J, Yaddanapudi SC, Pigati L, Havens MA, Jeong S, Weiner GA, Weimer KM, Stern B, Hastings ML, Duelli DM: MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res 2012; 40: 9125-9138.
14. Simons M, Raposo G: Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 2009; 21: 575-581.
15. Peinado H, Alekovi M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, Nitadori Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D: Melanoma exosomes educate bone marrow progenitor cells toward a prometastatic phenotype through MET. Nat Med 2012; 18: 883-891.
16. Tovar-Camargo OA, Toden S, Goel A: Exosomal microRNA biomarkers: emerging frontiers in colorectal and other human cancers. Expert Rev Mol Diagn 2016; 16: 553-567.
17. Hannafon BN, Ding WQ: Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci 2013; 14: 14240-14269.
18. Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al; Japanese Society for Cancer of the Colon and Rectum: Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol 2015; 20: 207-239.
19. Matsumura T, Sugimachi K, Iinuma H, Takahashi Y, Kurashige J, Sawada G, Ueda M, Uchi R, Ueo H, Takano Y, Shinden Y, Eguchi H, Yamamoto H, Doki Y, Mori M, Ochiya T, Mimori K: Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br J Cancer 2015; 113: 275-281.
20. Clancy C, Joyce MR, Kerin MJ: The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer. Cancer Biomark 2015; 15: 103-113.
21. Zekri AR, Youssef AS, Lotfy MM, Gabr R, Ahmed OS, Nassar A, Hussein N, Omran D, Medhat E, Eid S, Hussein MM, Ismail MY, Alenzi FQ, Bahnassy AA: Circulating serum miRNAs as diagnostic markers for colorectal cancer. PLoS One 2016; 11:e0154130.
22. Nedaeinia R, Sharifi M, Avan A, Kazemi M, Rafiee L, Ghayour-Mobarhan M, Salehi R: Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach. Cancer Gene Ther 2016; 23: 246-253.
23. Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, Pan J, Galandiuk S: Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann Surg 2012; 256: 544-551.
24. Luo X, Stick C, Burwinkel B, Brenner H: Identification and evaluation of plasma micro-RNAs for early detection of colorectal cancer. PLoS One 2013; 8:e62880.
25. Yamada A, Horimatsu T, Okugawa Y, Nishida N, Honjo H, Ida H, Kou T, Kusaka T, Sasaki Y, Yagi M, Higurashi T, Yukawa N, Amanuma Y, Kikuchi O, Muto M, Ueno Y, Nakajima A, Chiba T, Boland CR, Goel A: Serum miR-21, miR-29a, and miR-125b are promising biomarkers for the early detection of colorectal neoplasia. Clin Cancer Res 2015; 21: 4234-4242.
26. Basati G, Emami Razavi A, Abdi S, Mirzaei A: Elevated level of microRNA-21 in the serum of patients with colorectal cancer. Med Oncol 2014; 31: 205.
27. Du M, Liu S, Gu D, Wang Q, Zhu L, Kang M, Shi D, Chu H, Tong N, Chen J, Adams TS, Zhang Z, Wang M: Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Carcinogenesis 2014; 35: 2723-2730.
28. Yu W, Wang Z, Shen LI, Wei Q: Circulating microRNA-21 as a potential diagnostic marker for colorectal cancer: a meta-analysis. Mol Clin Oncol 2016; 4: 237-244.
29. Almeida AL, Bernardes MV, Feitosa MR, Peria FM, Tirapelli DP, Rocha JJ, Feres O: Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer. Acta Cir Bras 2016; 31(suppl 1): 13-18.
30. Montagnana M, Benati M, Danese E, Minicozzi AM, Paviati E, Gusella M, Pasini F, Bovo C, Guidi GC, Lippi G: Plasma expression levels of circulating miR-21 are not useful for diagnosing and monitoring colorectal cancer. Clin Lab 2016; 62: 967-970.
31. Menendez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menendez JM, Rodriguez-Montes JA: Prognostic implications of serum micro-RNA-21 in colorectal cancer. J Surg Oncol 2013; 108: 369-373.
32. Ye TT, Yang YL, Liu XY, Ji QQ, Pan YF, Xiang YQ: Prognostic value of circulating micro RNA-21 in digestive system cancers: a meta-analysis. Int J Clin Exp Med 2014; 7: 873-878.
33. Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A: Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 2013; 105: 849-859.
34. Inamura K, Ishikawa Y: MicroRNA in lung cancer: novel biomarkers and potential tools for treatment. J Clin Med 2016; 5:E36.
35. Jiang J, Yang P, Guo Z, Yang R, Yang H, Yang F, Li L, Xiang B: Overexpression of micro-RNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line. World J Surg Oncol 2016; 14: 278.
36. Rana S, Malinowska K, Zoller M: Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 2013; 15: 281-295.